home.social

#middleeastmarket — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #middleeastmarket, aggregated by home.social.

  1. Doosan Enerbility Co. has secured a 130 billion won ($99 million) contract to supply steam turbines and generators for a 2,400MW gas-fired power plant in Qatar, strengthening its presence in the Middle East energy market.
    #YonhapInfomax #DoosanEnerbility #Qatar #GasFiredPowerPlant #SteamTurbine #MiddleEastMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  2. Doosan Enerbility Co. has secured a 130 billion won ($99 million) contract to supply steam turbines and generators for a 2,400MW gas-fired power plant in Qatar, strengthening its presence in the Middle East energy market.
    #YonhapInfomax #DoosanEnerbility #Qatar #GasFiredPowerPlant #SteamTurbine #MiddleEastMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  3. Doosan Enerbility Co. has secured a 130 billion won ($99 million) contract to supply steam turbines and generators for a 2,400MW gas-fired power plant in Qatar, strengthening its presence in the Middle East energy market.
    #YonhapInfomax #DoosanEnerbility #Qatar #GasFiredPowerPlant #SteamTurbine #MiddleEastMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  4. Doosan Enerbility Co. has secured a 130 billion won ($99 million) contract to supply steam turbines and generators for a 2,400MW gas-fired power plant in Qatar, strengthening its presence in the Middle East energy market.
    #YonhapInfomax #DoosanEnerbility #Qatar #GasFiredPowerPlant #SteamTurbine #MiddleEastMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  5. Hanmi Pharmaceutical has signed a supply agreement with Saudi Arabia's Tabuk Pharmaceuticals to launch its FDA-approved neutropenia biologic 'Rolontis' in the Middle East, marking a major step in the company's global expansion strategy.
    #YonhapInfomax #HanmiPharmaceutical #Rolontis #TabukPharmaceuticals #Neutropenia #MiddleEastMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  6. Hanmi Pharmaceutical has signed a supply agreement with Saudi Arabia's Tabuk Pharmaceuticals to launch its FDA-approved neutropenia biologic 'Rolontis' in the Middle East, marking a major step in the company's global expansion strategy.
    #YonhapInfomax #HanmiPharmaceutical #Rolontis #TabukPharmaceuticals #Neutropenia #MiddleEastMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  7. Hanmi Pharmaceutical has signed a supply agreement with Saudi Arabia's Tabuk Pharmaceuticals to launch its FDA-approved neutropenia biologic 'Rolontis' in the Middle East, marking a major step in the company's global expansion strategy.
    #YonhapInfomax #HanmiPharmaceutical #Rolontis #TabukPharmaceuticals #Neutropenia #MiddleEastMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  8. Hanmi Pharmaceutical has signed a supply agreement with Saudi Arabia's Tabuk Pharmaceuticals to launch its FDA-approved neutropenia biologic 'Rolontis' in the Middle East, marking a major step in the company's global expansion strategy.
    #YonhapInfomax #HanmiPharmaceutical #Rolontis #TabukPharmaceuticals #Neutropenia #MiddleEastMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV